Galena Biopharma Inc (NASDAQ:GALE) investors have sent shares flying almost 17% this morning following the drug maker’s buzz-worthy news: shareholders said yes to …
Galena Biopharma Inc (NASDAQ: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum …
Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …
Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum …
Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer …
Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum …
Roth Capital analyst Joseph Pantginis maintained a Buy rating on Galena Biopharma (NASDAQ:GALE) with an $8.00 price target, after the company reported its FY2014 financial …
Maxim’s healthcare analyst Jason Kolbert weighed in with his thoughts on Galena Biopharma (NASDAQ:GALE), after the company announced enrollment of the 700th patient in the …
In a research report published Thursday, MLV analyst Vernon Bernardino maintained a Buy rating on Galena Biopharma (NASDAQ:GALE) with a $5 price target, following …
